Literature DB >> 19596019

Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice.

Soichiro Ide1, Ichiro Sora, Kazutaka Ikeda, Masabumi Minami, George R Uhl, Kumatoshi Ishihara.   

Abstract

The detailed mechanisms of emotional modulation in the nervous system by opioids remain to be elucidated, although the opioid system is well known to play important roles in the mechanisms of analgesia and drug dependence. In the present study, we conducted behavioral tests of anxiety and depression and measured corticosterone concentrations in both male and female mu-opioid receptor knockout (MOP-KO) mice to reveal the involvement of mu-opioid receptors in stress-induced emotional responses. MOP-KO mice entered more and spent more time in the open arms of the elevated plus maze compared with wild-type mice. MOP-KO mice also displayed significantly decreased immobility in a 15 min tail-suspension test compared with wild-type mice. Similarly, MOP-KO mice exhibited significantly decreased immobility on days 2, 3, and 4 in a 6 min forced swim test conducted for 5 consecutive days. The increase in plasma corticosterone concentration induced by tail-suspension, repeated forced swim, or restraint stress was reduced in MOP-KO mice compared with wild-type mice. Corticosterone levels were not different between wild-type and MOP-KO mice before stress exposure. In contrast, although female mice tended to exhibit fewer anxiety-like responses in the tail-suspension test in both genotypes, no significant gender differences were observed in stress-induced emotional responses. These results suggest that MOPs play an important facilitatory role in emotional responses to stress, including anxiety- and depression-like behavior and corticosterone levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596019      PMCID: PMC4103702          DOI: 10.1016/j.neuropharm.2009.07.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  39 in total

Review 1.  Molecular control of locus coeruleus neurotransmission.

Authors:  E J Nestler; M Alreja; G K Aghajanian
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

2.  Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses.

Authors:  D Filliol; S Ghozland; J Chluba; M Martin; H W Matthes; F Simonin; K Befort; C Gavériaux-Ruff; A Dierich; M LeMeur; O Valverde; R Maldonado; B L Kieffer
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

3.  BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.

Authors:  S Kõks; A Soosaar; V Võikar; M Bourin; E Vasar
Journal:  Neuropeptides       Date:  1999-02       Impact factor: 3.286

4.  Factor analysis shows that female rat behaviour is characterized primarily by activity, male rats are driven by sex and anxiety.

Authors:  C Fernandes; M I González; C A Wilson; S E File
Journal:  Pharmacol Biochem Behav       Date:  1999-12       Impact factor: 3.533

5.  Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice.

Authors:  Jakub Fichna; Anna Janecka; Mariola Piestrzeniewicz; Jean Costentin; Jean-Claude do Rego
Journal:  Neuropsychopharmacology       Date:  2006-07-05       Impact factor: 7.853

Review 6.  Opioids: first lessons from knockout mice.

Authors:  B L Kieffer
Journal:  Trends Pharmacol Sci       Date:  1999-01       Impact factor: 14.819

Review 7.  The effect of gonadal hormones and gender on anxiety and emotional learning.

Authors:  Donna J Toufexis; Karyn M Myers; Michael Davis
Journal:  Horm Behav       Date:  2006-08-14       Impact factor: 3.587

8.  Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects.

Authors:  J C Chen; K W Liang; E Y Huang
Journal:  Synapse       Date:  2001-03-01       Impact factor: 2.562

9.  Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression.

Authors:  Esther Berrocoso; Juan-Antonio Mico
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-03       Impact factor: 5.176

Review 10.  Region- and sex-specific modulation of anxiety behaviours in the rat.

Authors:  D Toufexis
Journal:  J Neuroendocrinol       Date:  2007-06       Impact factor: 3.627

View more
  15 in total

Review 1.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

2.  Effect of OPRM1 and stressful life events on symptoms of major depression in African American adolescents.

Authors:  Gregory Swann; Gayle R Byck; Danielle M Dick; Fazil Aliev; Shawn J Latendresse; Brien Riley; Darlene Kertes; Cuie Sun; Jessica E Salvatore; John Bolland; Brian Mustanski
Journal:  J Affect Disord       Date:  2014-03-27       Impact factor: 4.839

3.  A role for the mu opioid receptor in the antidepressant effects of buprenorphine.

Authors:  Shivon A Robinson; Rebecca L Erickson; Caroline A Browne; Irwin Lucki
Journal:  Behav Brain Res       Date:  2016-11-03       Impact factor: 3.332

4.  Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity.

Authors:  Jérôme A J Becker; Daniel Clesse; Coralie Spiegelhalter; Yannick Schwab; Julie Le Merrer; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2014-03-12       Impact factor: 7.853

5.  Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.

Authors:  Soichiro Ide; Shunsuke Fujiwara; Masayuki Fujiwara; Ichiro Sora; Kazutaka Ikeda; Masabumi Minami; George R Uhl; Kumatoshi Ishihara
Journal:  J Pharmacol Sci       Date:  2010-08-10       Impact factor: 3.337

6.  Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans.

Authors:  Anya K Bershad; Jerome H Jaffe; Emma Childs; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2014-12-09       Impact factor: 4.905

7.  Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway.

Authors:  David Carlson; Lisa K David; Neil M Gallagher; Mai-Anh T Vu; Matthew Shirley; Rainbo Hultman; Joyce Wang; Caley Burrus; Colleen A McClung; Sunil Kumar; Lawrence Carin; Stephen D Mague; Kafui Dzirasa
Journal:  Biol Psychiatry       Date:  2017-06-15       Impact factor: 13.382

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

9.  Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol.

Authors:  Jérôme A J Becker; Brigitte L Kieffer; Julie Le Merrer
Journal:  Addict Biol       Date:  2016-04-28       Impact factor: 4.280

10.  Possible Involvement of µ Opioid Receptor in the Antidepressant-Like Effect of Shuyu Formula in Restraint Stress-Induced Depression-Like Rats.

Authors:  Fu-Rong Wang; Ming-Qi Qiao; Ling Xue; Sheng Wei
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.